New Implementing Act, Annex VII: Time to Market - Predictability & Increased Transparency
Learn about the new Implementing Act on Annex VII and gain insight into the changes designed to improve predictability, transparency, and consistency in Notified Bodies’ conformity assessments.
Background
Implementing act on uniform application of the requirements for Notified Bodies (Annex VII) was published 4 May 2026 to address inconsistent interpretations of Annex VII by NBs, enhancing predictability, transparency, and consistency in conformity assessments.
The Act introduces maximum timelines for conformity assessments, such as technical documentation review and QMS audits, aiming to reduce delays in certification, including re-certification. Also, the act establishes uniform procedures for Notified Bodies regarding how they request information and provide cost estimates, aiming to reduce fragmentation and improve treatment for SMEs.
Join the seminar and get to know all the important details!
Tentative program
14.00 - 14.05 Welcome by Mads Koch Hansen, CEO, Medicoindustrien
14.05 - 14.20 Introduction
Lene Laursen, Deputy Director, Medicoindustrien
Kaja Tengbjerg, Chief Consultant, Medicoindustrien
14.20 - 15.20 Overview of the Changes in Annex VII
The Danish Medicines Agency (Confirmed)
15.20 - 15.40 Coffee break
15.40 - 16.10 Notified Body Perspective on Deadlines and Collaboration
with the Manufacturers
BSI (Confirmed)
16.10 - 16.40 Perspective Deadlines and Collaboration
with the Manufacturers
Tüv Süd (Confirmed)
16.40 - 16.50 Wrap-Up and conclusions by Medicoindustrien
Who should attend
The seminar is relevant for RA, QA and management of manufacturers of all sizes who want to gain knowledge about Annex VII from both Notified Bodies and The Danish Medicines Agency.
